Information  X 
Enter a valid email address

Broker Forecast - Numis issues a broker note on Circassia Pharmaceuticals Plc

By BFN News | 12:10 PM | Tuesday 24 April, 2018


Numis today reaffirms its buy investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and cut its price target to 140p (from 180p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t